Ashley Wright, Obstetrics & Gynecology - Gynecologic Oncology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 |
Dr. Emily Mills Craner, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3686 Grandview Pkwy Ste 320, Birmingham, AL 35243 Phone: 205-971-5499 Fax: 205-971-5438 |
Dr. Emily K Osman, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 619 19th St S, Birmingham, AL 35233 Phone: 205-996-3130 |
John B Woods, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: University Of Alabama At Birmingham Dept Of, 176f Rm 5325, 619 19th Street S, Birmingham, AL 35249 Phone: 205-996-3310 Fax: 205-975-6411 |
Susanna E Carter, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 800 Saint Vincents Dr Ste 500, Birmingham, AL 35205 Phone: 205-933-8334 Fax: 205-933-8466 |
News Archive
Abbott has announced that it has received merger control clearance from the European Commission for its acquisition of Advanced Medical Optics (AMO) through a cash tender offer for the outstanding shares of common stock of AMO.
The simple act of picking up a pencil requires the coordination of dozens of muscles: The eyes and head must turn toward the object as the hand reaches forward and the fingers grasp it. To make this job more manageable, the brain's motor cortex has implemented a system of shortcuts. Instead of controlling each muscle independently, the cortex is believed to activate muscles in groups, known as "muscle synergies." These synergies can be combined in different ways to achieve a wide range of movements.
In a new study that appeared in the International Journal of Obesity, researchers have found that stress may affect sleep, mood and ultimately body weight. The study found that people with high stress and poor sleep were less likely to achieve a 10-lb. weight loss goal.
Extended exposure to the psoriasis medication etanercept does not appear to cause more infections or adverse events than placebo, and improvements in several measures of disease severity were observed for up to 96 weeks of therapy, according to a study in the June issue of Archives of Dermatology.
Halozyme Therapeutics, Inc. today announced Phase 2 results demonstrating that the subcutaneous coinjection of rHuPH20 (recombinant human hyaluronidase, PH20) with lispro significantly improves postprandial hyperglycemia, reduces hypoglycemia, and accelerates the absorption of mealtime insulin in patients with type 2 diabetes.
› Verified 5 days ago